Dr. Nicholas Tranakas, MD

Dr. Tranakas practices at Broward Surgical Associates, Inc. in Fort Lauderdale, Florida.

Dr. Tranakas' NPI, 1982790184, was assigned on October 5, 2006. Dr. Tranakas graduated from University of Miami, Miller School of Medicine in 1987. Dr. Tranakas holds Florida license ME56834.

Dr. Tranakas' primary practice is Broward Surgical Associates, Inc., at 2006 Ne 49th St, Fort Lauderdale, FL 33308 in Broward County. The practice phone is (954) 491-0900.

Dr. Tranakas' primary practice is Broward Surgical Associates, Inc. in Fort Lauderdale, Florida. Dr. Tranakas is also affiliated with Holy Cross Health. The medical group on file is Broward Surgical Associates. Dmand AI also links Dr. Tranakas to 4 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tranakas practices, 7 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Tranakas' primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Tranakas is board certified in surgery by the American Board of Surgery. Dr. Tranakas is licensed in Florida.

Dmand AI lists breast surgery, cancerous skin growth removal and mastectomy among the conditions Dr. Tranakas treats.

CMS data shows 439 Medicare services from Dr. Tranakas across 2 procedure codes in 2024, all of them office visits, for 343 Medicare patients. Medicare paid $32,902 for them. Every service was in an office.

CMS counts 343 Medicare patients who saw Dr. Tranakas in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Tranakas' median patient age at 69, with 92% women.

In 2024, Dr. Tranakas wrote 84 Medicare Part D claims for 82 patients. 100% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $200 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tranakas for performance year 2024, reported individually. Dr. Tranakas accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of mastectomy by Dr. Tranakas, more than 89% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Tranakas in 2024. 2024 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Mastectomy and Surgical Oncology. Dr. Tranakas has published most often in Ann Surg Oncol. Dr. Tranakas' most frequent co-authors are Doreen M. Agnese, MD, Andrea V. Barrio, MD and Judy C. Boughey, MD.

CMS Open Payments shows 9 general payments to Dr. Tranakas from 7 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 95% of the total. Solventum Corporation paid the most, $264.

Dmand AI lists 4 awards for Dr. Tranakas, most recently Gulfstream FL-Broward in 2013.

Dr. Tranakas graduated from University of Miami, Miller School of Medicine in 1987. Dr. Tranakas is a member of ACS and SLS.

Dr. Tranakas is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.